Kalobios Pharmaceuticals Inc.
Formerly Horizon Biotechnologies, Inc.
Funding rounds
3 counted as startup funding. Open the number of investors for the round's details.
How it makes money#
What its filings and its own website say, sentence by sentence, each with its source.
Kalobios Pharmaceuticals Inc. chose not to state its revenue in its newest notice of a funding round (Jul 2016).
SEC Form D · Jul 2016
The industry group it chose in its notices: Other.
SEC Form D · Jul 2016
Products and services#
No products or services on record: no website is on record for it in an official source (its SEC filings, Wikidata).
Investors#
No investor of Kalobios Pharmaceuticals Inc. is named in an official source we use. Its funding notices give only how many investors bought, not who they are.
Executives and directors
As the company named them in its notices. Directors of a funded startup are often partners of its investors.
| Name | Role | Named in |
|---|---|---|
| Cameron Durrant | Executive officer | Jul 2016 |
| Dean Witter III | Executive officer | Jul 2016 |
| Morgan Lam | Executive officer | Jul 2016 |
| David Pritchard | Executive officer | May 2012 |
| Jeanne Jew | Executive officer | May 2012 |
| Cameron Durrant | Director | Jul 2016 |
| Dale Chappell | Director | Jul 2016 |
| Ezra Friedberg | Director | Jul 2016 |
| Ronald Barliant | Director | Jul 2016 |
| Timothy Morris | Director | Jul 2016 |
| David Moradi | Director | Jan 2016 |
| Michael Harrison | Director | Jan 2016 |
| Brigitte Smith | Director | May 2012 |
| David Pritchard | Director | May 2012 |
| Denise Gilbert | Director | May 2012 |
| Dennis Henner | Director | May 2012 |
| Gary Lyons | Director | May 2012 |
| James Healy | Director | May 2012 |
| Ray Withy | Director | May 2012 |
| Ted Love | Director | May 2012 |